Plain-English translation of NCT07115329 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Major Depressive Disorder research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 clinical trial testing whether , a new medication taken once per week, can safely reduce the symptoms of major depressive disorder. About 164 people will participate by either taking the medication or an inactive placebo (a fake pill) for 6 weeks. Researchers will measure how much depression symptoms improve and watch for any side effects.
Many people with depression don't find relief with existing antidepressants, and taking medication every day can be challenging for some patients. This trial explores whether this new treatment approach—given just once a week instead of daily—could be both effective and easier for patients to use.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic about 10 times over roughly 3 months: first for screening, then weekly during 6 weeks of treatment, and finally for a follow-up visit. At each visit, you'll take your assigned pill (either the new medication or placebo) and answer questions about how you're feeling. Study doctors will use a standardized rating scale to measure your depression and check for any side effects.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States